Dry AMD is a leading cause of vision loss among older Americans and as of this writing, has no treatment. In a potentially breakthrough study, the first U.S.-based AMD patient has been treated in the phase 1/2a clinical trial (NCT04339764) of an autologous induced pluripotent stem cell (iPSC) therapy for the treatment of dry age-related macular degeneration (AMD) by the NIH. … [Read more...] about NIH: First U.S. patient receives autologous stem cell therapy to treat dry AMD
Vision / Blindness
Stem Cells – The Cure for Blindness?
In the United States alone, over 7 million people - regardless of age, race, and gender - suffer from a visual disability, in statistics reported by the National Federation of the Blind (NFB). Most conditions afflicting vision are irreversible and/or require advanced, invasive - and sometimes risky - techniques. For example, patients suffering from the disease … [Read more...] about Stem Cells – The Cure for Blindness?
Stem Cells to Restore Vision for AMD Patients
There is a new technique currently being tested to restore vision in those suffering from age-related macular degeneration (AMD) with stem cells. Over the course of 18 months, 10 patients will undergo the treatment at the Moorfields Eye Hospital in London. The first patient in the UK received the emperimental treatment earlier this year and doctors will know if it was … [Read more...] about Stem Cells to Restore Vision for AMD Patients